High mutation frequency of ZFP36L1 (7%) was also confirmed in the 412 BC cases from the Cancer Genome Atlas (TCGA) (Cancer Genome Atlas Research, 2014; Robertson et al., 2017). This evidence concerns the gene ZFP36L1 and breast cancer.